Shopping Cart
- Remove All
Your shopping cart is currently empty
CD73-IN-3 (LY-3475070) is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $58 | In Stock | |
| 5 mg | $148 | In Stock | |
| 10 mg | $238 | In Stock | |
| 25 mg | $398 | In Stock | |
| 50 mg | $567 | In Stock | |
| 100 mg | $768 | In Stock | |
| 200 mg | $987 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $163 | In Stock |
| Description | CD73-IN-3 (LY-3475070) is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer. |
| Targets&IC50 | CD73:28 nM |
| Synonyms | LY-3475070, EX-A4254 |
| Molecular Weight | 286.33 |
| Formula | C15H18N4O2 |
| Cas No. | 2375815-63-5 |
| Smiles | [H][C@@]1(C[C@@H]1C(C)C)c1cc(nnc1C)-c1c[nH]c(=O)[nH]c1=O |
| Relative Density. | 1.245 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 22.5 mg/mL (78.58 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.